Majić T
Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Berlin, Germany.
ArticlePsilocybin
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.
PreprintPsychedelics
Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences
ArticlePsychedelics
Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management.
ArticlePsilocybin
Classifying Psychedelic-Related Complications.
ArticlePsilocybin
Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.
ArticlePsychedelics
Managing Psychological Challenges in the Subacute ("Afterglow") Window of Psychedelic Drug Effects.
ArticlePsilocybin
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics.
ArticlePsilocybin
Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.
ArticlePsychedelics
On Minimizing Risk and Harm in the Use of Psychedelics.
ArticlePsilocybin
Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.
ArticleMDMA
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.
ArticlePsilocybin
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.
ArticleLSD
Dose-response relationships of LSD-induced subjective experiences in humans.
PreprintLSD
Dose-response relationships of LSD-induced subjective experiences in humans
ArticlePsilocybin
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.
ArticlePsychedelics
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey.
ArticlePsilocybin
Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.
ArticleAyahuasca
Connected to the spirit of the frog: An Internet-based survey on Kambô, the secretion of the Amazonian Giant Maki Frog (<i>Phyllomedusa bicolor</i>): Motivations for use, settings and subjective experiences.
ArticlePsychedelics
Acute and subacute psychoactive effects of Kambô, the secretion of the Amazonian Giant Maki Frog (Phyllomedusa bicolor): retrospective reports.
ArticlePsilocybin
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.
ArticlePsilocybin